Showing results (331-340 of 403) with videos related to

Sort By:
Pageof 41
Targeted Oncology|February 6, 2020
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 StudyLuca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Scientific Reports|July 2, 2025
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNAAlessandra Virga, Milena Urbini, Maurizio Polano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose ChemotherapyMilena Urbini, Thomas F Eleveld, Maurizio Polano, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 21, 2024
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING studyElisabetta Petracci, Luigi Pasini, Milena Urbini, et al.
Oncotarget|April 9, 2016
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS studyAndrea Casadei Gardini, Giorgia Marisi, Luca Faloppi, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry ExperienceKalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, et al.
Cancers|July 24, 2019
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving SorafenibGiorgia Marisi, Elisabetta Petracci, Francesco Raimondi, et al.
Pageof 41